Gallarate, Italy

Osvaldo Sapini


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1985-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Osvaldo Sapini: Innovator in Ergoline Derivatives

Introduction

Osvaldo Sapini is a notable inventor based in Gallarate, Italy. He has made significant contributions to the field of pharmacology through his innovative work on ergoline derivatives. With a total of 2 patents to his name, Sapini's inventions focus on compounds with therapeutic potential.

Latest Patents

One of his latest patents is related to Ergoline carboxamides. This patent provides a detailed description of ergoline derivatives characterized by specific chemical formulas. The compounds exhibit strong antiprolactin activity, which could have important implications in medical treatments. Another significant patent is for Dimethylaminoalkyl-3-(ergoline-8'.beta.carbonyl)-ureas. These novel ergoline derivatives are formed through the reaction of an 8-carboxy ergoline with a carbodiimide, showcasing hypotensive and antiprolatinic activity.

Career Highlights

Osvaldo Sapini is associated with Farmitalia Carlo Erba S.p.a., a company known for its focus on pharmaceutical innovations. His work at this institution has allowed him to explore and develop new therapeutic compounds that can benefit various medical fields.

Collaborations

Throughout his career, Sapini has collaborated with notable colleagues such as Aldemio Temperilli and Enrico Di Salle. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Osvaldo Sapini's contributions to the field of pharmacology through his innovative patents on ergoline derivatives highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…